The Rise of Discount Cigarette Brands in the US

Feb.17
The Rise of Discount Cigarette Brands in the US
JTI predicts over 40% of US market will be discount cigarettes by 2027, due to economic pressures on consumers.

According to a recent report by Reuters, Japan Tobacco International (JTI) predicts that by 2027, the market share of budget cigarette brands in the United States will exceed 40%.


In recent years, due to high inflation and rising interest rates, consumers are facing increased economic pressure. As a result, American smokers are gradually shifting away from traditional cigarette brands like Altria's Marlboro and British American Tobacco's Newport, which have been consistently raising prices for years, and towards lower-priced brands.


British American Tobacco announced on Thursday that its cigarette sales in the United States decreased by 10.1% in 2024, partly due to brand switching. Meanwhile, Altria's market share also declined.


These companies hope that this trend is temporary, and expect that as economic pressures ease, consumers will return to traditional brands. However, Vassilis Vovos, the Chief Financial Officer of Japan Tobacco International (JTI), stated in an interview with Reuters that even as affordability improves, higher-priced brands may continue to lose market share.


This is a very stubborn trend, and we expect it to continue.


He added that the price increase will continue to drive consumers to choose cheaper brands.


In order to drive revenue growth in the face of declining smoking rates, tobacco giants such as Altria and British American Tobacco (BAT) are relying on price-hiking strategies in the U.S. market to support their revenue growth in markets like the United States. Japan Tobacco International (JTI) predicts that low-price and super low-price brands will account for 42% of the market by 2027, compared to around 32% in 2022.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
Production|HQD Launches APEX With 1.47" HD Screen and 5-45W Output
Production|HQD Launches APEX With 1.47" HD Screen and 5-45W Output
HQD recently launched the open e-cigarette APEX, equipped with a 1.47-inch HD touchscreen with 5-45W wide-range power output, supporting three kinds of interchangeable cartridges of 0.4Ω, 0.8Ω and 1.2Ω, and adapted to MTL to DTL modes. The product has been launched on the brand's official website and social media, but has not yet landed on overseas distributor platforms.
Apr.28 by 2FIRSTS.ai
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
As part of its GFN media partnership, 2Firsts spoke with FCTC expert Jeannie Cameron, who warns that the WHO’s rejection of harm reduction is leading global tobacco control efforts off course.
Jun.18
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris launches new HNB product "IQOS ILUMA i One".
Philip Morris International introduces new HNB product IQOS ILUMA i One in South Korea for $45.
Jun.12 by 2FIRSTS.ai
Estonia Bans Flavored Heated Tobacco Sales from Feb 2026 Under New Law
Estonia Bans Flavored Heated Tobacco Sales from Feb 2026 Under New Law
Estonia’s parliament has passed an amendment to the Tobacco Act, banning the sale of flavored and scented heated tobacco products starting January 31, 2026. The revision sets rules on product composition, labeling, and penalties for violations. Manufacturers must submit product information to health authorities before market entry.
Apr.24 by 2FIRSTS.ai
From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
At Vaper Expo UK, CFU Vaping Experience launched Prime 2ML, a superior alternative to traditional disposables, and Prime 10ML, a compliant solution for legal big puff. MixIn, the first smart hybrid device combining harm reduction with enhanced flavor, provides a viable option for smokers. Through technological innovation, CFU has brought sustainable solutions to the industry, leading it into a new “Prime Time.”
May.12